Regardless of the patient age, PLC should be considered in differential diagnoses of progressive dyspnea, acute respiratory failure, and widespread interstitial lung involvement.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Pulmonary lymphangitic carcinomatosis (PLC) is defined as infiltration of the lymphatic vessels and perilymphatic connective tissue with tumor cells, which is secondary to malignancy.
📊
Key Findings & Data:A 30-year-old male patient was hospitalized in our clinic with a pre-diagnosis of interstitial lung disease owing to the complaints of dry cough, progressive dyspnea, and acute respiratory insufficiency.
💡
Conclusion & Impact:Regardless of the patient age, PLC should be considered in differential diagnoses of progressive dyspnea, acute respiratory failure, and widespread interstitial lung involvement.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Pulmonary lymphangitic carcinomatosis (PLC) is defined as infiltration of the lymphatic vessels and perilymphatic connective tissue with tumor cells, which is secondary to malignancy. Therefore, it rarely appears as an initial finding preceding a diagnosis of malignancy. A 30-year-old male patient was hospitalized in our clinic with a pre-diagnosis of interstitial lung disease owing to the complaints of dry cough, progressive dyspnea, and acute respiratory insufficiency. He was diagnosed with signet ring cell carcinoma, which is a histologic subtype of adenocarcinoma, via gastroscopy, and lung involvement was consistent with PLC. Regardless of the patient age, PLC should be considered in differential diagnoses of progressive dyspnea, acute respiratory failure, and widespread interstitial lung involvement.
🔖
Cite This Article
AĞCA, M., AKYIL, F. T., HÖRMET, M., AKMAN, O., AKMAN, C., ŞEN, A., SEVİM, T. (2017). A Rare Case of Progressive Dyspnea and Bilateral Lung Infiltration in a Young Male. Turkish Thoracic Journal, Cilt: 18 - Sayı: 3, 96–99. https://ajindex.com/articles/418088
Bruce DM, Heys SD, Eremin O. Lymphangitis carcinomatosa: A literature review. J R Coll Surg Edinb 1996;41:7-13
Zhang K, Huang Y. Clinical features and diagnosis of pulmonary lymphangitic carcinomatosis. Ai Zheng 2006;25:1127-30
Naidich DP, Srichai MB, Krinsky GA. Computed tomography and magnetic resonance of the thorax. Lippincott Williams & Wilkins. 4th ed. Philadelphia: 2007. ISBN:0781757657
Kazerooni EA, Gross BH. Cardiopulmonary imaging. Lippincott Williams & Wilkins. Philadelphia 2004. ISBN:0781736552
Ikezoe J, Godwin JD, Hunt KJ. Pulmonary lymphangitic carcinomatosis: chronicity of radiographic findings in long-term survivors. AJR Am J Roentgenol 1995;165:49-52. [CrossRef] 6. Taghavi S, Jayajaran S, Davey A, Willis A. Prognostic significance of signet ring gastric cancer. Am Soc Clin Oncol 2012;30:3493- 98. [CrossRef] 7. Moubax K, Wuyts W, Vandecaveye V, Prenen H. Pulmonary lymphangitic carcinomatosis as a gastric carcinoma in a young adult: case report and review of the literature. BMC Research Notes 2012;5:638. [CrossRef] 8. Doyle L. Gabriel Andral (1797-1876) and the first reports of lymphangitis carcinomatosa. J R Soc Med 1989;82:491-3
Desigan G, Wang M, Wofford B, et al. Occult gastric cancer manifested by progressive shortness of breath in a young adult. Southern Med J 1986;79:1173-6. [CrossRef] 10. Grenier P, Chevret S, Beigelman C, et al. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology 1994;191:383-90. [CrossRef] 11. Cömert SS, Doğan C, Çağlayan B, et al. The features of lymphangitis carcinomatosa cases. Izmir Chest Hosp Journal 2013;27:173-80
Sengelen M. Cancer Statistics in Turkey. Hacettepe University Institute of Medical Sciences, Epidemiology Master’s Thesis, Ankara, 2002
Boland Cr, Scheiman JM. Tumors of the stomach. In: Yamada T, Alpers DH, Oweyang C et al. eds. Textbook of Gastroenterology. 2nd ed. Philedelphia: J.B.Lippincontt; 1995:1495-1523
Piessen G, Messager M, Leteurtre E, et al. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg 2009;250:878-87.[CrossRef]